It is a healthcare limited liability partnership based in Kolkata, West Bengal, India, established in 2016.
2016 | Kolkata, West Bengal, India | ActiveBiommune Pharma Technologies Llp, a active limited liability partnership, was established on 04 February 2016 in Kolkata, West Bengal, India. Engaging in hospitals within the healthcare sector, it holds LLPIN: AAF-6355. Registered under ROC Roc Kolkata. It has total obligation of contribution of ₹1.00 Cr.
Employing 10 professional, Its leadership includes Bithin Biswas (Designated Partner), Shib Sankar Nagsarkar (Designated Partner), Mrityunjoy Mondal (Designated Partner). Past directors included Debasis Karmakar, Aranya Sarkar. Its latest date of accounts and solvency statement 31 March 2024. It is based at 149, Cit Road Scheme Vi-M Kankurgachi, Kolkata, West Bengal, 700054.
AAF-6355
04 February 2016
₹1.00 Cr
Roc Kolkata
Active
Explore comprehensive insights into Biommune Pharma Technologies Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bithin Biswas | Designated Partner | 04 Feb 2016 | Current |
| Shib Sankar Nagsarkar | Designated Partner | 04 Feb 2016 | Current |
| Mrityunjoy Mondal | Designated Partner | 04 Feb 2016 | Current |
| Joydeb Bhattacharjee | Designated Partner | 04 Feb 2016 | Current |
| Buddhadeb Biswas | Designated Partner | 04 Feb 2016 | Current |
| Gopi Nath Dey | Designated Partner | 04 Feb 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Partner | - | Past |
| Pramod Abcsdd | Partner | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Biommune Pharma Technologies Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Biommune Pharma Technologies Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no Open Charges registered against the LLP as per our records.
Biommune Pharma Technologies Llp has a workforce of 6 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Biommune Pharma Technologies Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biommune Pharma Technologies Llp's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Biommune Pharma Technologies Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was completed.
Biommune Pharma Technologies Llp has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kolkata. was recorded as a recent event.
Bithin Biswas was appointed as a Designated Partner was appointed as a Designated Partner on 04 Feb 2016 & has been associated with this company since 9 years 9 months . was recorded as a recent event.
The activity Shib Sankar Nagsarkar was appointed as a Designated Partner was appointed as a Designated Partner on 04 Feb 2016 & has been associated with this company since 9 years 9 months . was completed.
Mrityunjoy Mondal was appointed as a Designated Partner was appointed as a Designated Partner on 04 Feb 2016 & has been associated with this company since 9 years 9 months . was recorded as a recent event.
Progress on Joydeb Bhattacharjee was appointed as a Designated Partner was appointed as a Designated Partner on 04 Feb 2016 & has been associated with this company since 9 years 9 months . was documented.
The LLPIN of Biommune Pharma Technologies Llp is AAF-6355.
Biommune Pharma Technologies Llp is headquartered at 149, Cit Road Scheme Vi-M Kankurgachi, Kolkata, West Bengal, 700054.
Biommune Pharma Technologies Llp was incorporated on 04 February 2016.
The current directors of Biommune Pharma Technologies Llp are
The primary industry of Biommune Pharma Technologies Llp is Healthcare.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX